LABORATORY KITS

Brand Owner (click to sort) Address Description
CONCEPT IVOCLAR VIVADENT, INC. 175 Pineview Drive Amherst NY 14228 Laboratory kits, sold as a unit in the professional dental field, used for the fabrication and cementation of dental inlays and onlays for tooth restoration, primarily composed of coloring materials, namely, resin filled pastes used for characterization; fluids and gels, namely, isolating and modeling liquid used in the fabrication process; dental polishing paste; and heat pressured resin material for fabricating crowns and bridges; along with composite material including a base, dentin and enamel material; as well as dental modeling instruments and brushes designed for handling the materials in the fabrication process;
CONCEPT HP IVOCLAR VIVADENT, INC. 175 Pineview Drive Amherst NY 14228 Laboratory kits, sold as a unit in the professional dental field, used for the fabrication of dental inlays and onlays for tooth restoration, primarily composed of coloring materials, namely, resin filled pastes used for characterization; fluids and gels, namely, isolating and modeling liquid used in the fabrication process; and dental polishing paste; along with composite material including a base, dentin and enamel material; dental modeling instruments and brushes designed for handling the materials in the fabrication process;
CORTISET HYCEL, INC. Houston TX LABORATORY KITS, INCLUDING INSTRUCTIONS AND TESTING MATERIALS, AND LABORATORY CHEMICAL REAGENTS, BOTH OF WHICH ARE USED FOR 17-KETOSTEROID AND 17-KETOGENIC STEROID DETERMINATIONS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides methods, compositions and kits for discriminating between COX-1 and COX-2 activity. In particular, the prevent invention provides for the detection and/or measurement of COX-2 activity in subjects, samples thereof, and in laboratory tests. The present invention discloses that 2-arachidonylglycerol is a COX-2 selective substrate which is metabolized by COX-2 to prostaglandin glycerol esters (PG-Gs) and that the diversity of PG-Gs parallels that of arachidonic acid derived metabolites of COX. The present invention also provides certain novel COX-2 selective metabolites including prostaglandin I2-glycerol ester (PGI2-G) and 6-keto-prostaglandin F1a-glycerol ester. Methods and kits are described for detecting COX-2 activity comprising detecting PG-Gs (including the novel PG-Gs disclosed herein). Uses for these methods and kits include the detection and monitoring of inflammation and tumors or cancer. Additional uses include the monitoring of test agents in assays to screen for COX-2 specific inhibitors and other laboratory uses.